tradingkey.logo
tradingkey.logo
Search

Quest Diagnostics Inc

DGX
Add to Watchlist
188.070USD
-2.110-1.11%
Market hours ETQuotes delayed by 15 min
20.88BMarket Cap
20.42P/E TTM

Quest Diagnostics Inc

188.070
-2.110-1.11%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

-1.11%

5 Days

-1.45%

1 Month

-1.80%

6 Months

+0.65%

Year to Date

+8.38%

1 Year

+6.92%

Key Insights

Quest Diagnostics Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 17 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 221.70.In the medium term, the stock price is expected to remain stable.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Quest Diagnostics Inc's Score

Industry at a Glance

Industry Ranking
17 / 75
Overall Ranking
95 / 4490
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Positive

Quest Diagnostics Inc Highlights

StrengthsRisks
Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 19.27% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 11.04B.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 38.22%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 38.22%.
Fairly Valued
The company’s latest PE is 20.65, at a medium 3-year percentile range.
Institutional Selling
The latest institutional holdings are 110.61M shares, decreasing 2.78% quarter-over-quarter.
Held by CI Select Canadian Equity Fund
Star Investor CI Select Canadian Equity Fund holds 1.70K shares of this stock.

Analyst Rating

Based on 20 analysts
Buy
Current Rating
221.702
Target Price
+18.31%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Quest Diagnostics Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Quest Diagnostics Inc Info

Quest Diagnostics Incorporated is a provider of diagnostic information services. The Company provides diagnostic insights from the results of its laboratory testing to enable people, physicians, and organizations to take action to improve health outcomes. It operates through the DIS segment, which provides diagnostic information services to a range of customers within its primary customer channels: physicians, hospitals, and patients and consumers. It offers broad access to clinical testing through a nationwide network of laboratories, patient service centers, phlebotomists in physician offices, and connectivity resources, including call centers and mobile phlebotomists, nurses and other health and wellness professionals. It also focuses on artificial intelligence (AI) and digital pathology solutions. The Company’s services primarily are provided under the Quest Diagnostics brand and under other brands, including AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum.
Ticker SymbolDGX
CompanyQuest Diagnostics Inc
CEODavis (James E)
Websitehttps://www.questdiagnostics.com/
KeyAI